Oxidation of KCNB1 Potassium Channels Causes Neurotoxicity and Cognitive Impairment in a Mouse Model of Traumatic Brain Injury
Open Access
- 26 October 2016
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 36 (43) , 11084-11096
Abstract
The delayed rectifier potassium (K+) channel KCNB1 (Kv2.1), which conducts a major somatodendritic current in cortex and hippocampus, is known to undergo oxidation in the brain, but whether this can cause neurodegeneration and cognitive impairment is not known. Here, we used transgenic mice harboring human KCNB1 wild-type (Tg-WT) or a nonoxidable C73A mutant (Tg-C73A) in cortex and hippocampus to determine whether oxidized KCNB1 channels affect brain function. Animals were subjected to moderate traumatic brain injury (TBI), a condition characterized by extensive oxidative stress. Dasatinib, a Food and Drug Administration–approved inhibitor of Src tyrosine kinases, was used to impinge on the proapoptotic signaling pathway activated by oxidized KCNB1 channels. Thus, typical lesions of brain injury, namely, inflammation (astrocytosis), neurodegeneration, and cell death, were markedly reduced in Tg-C73A and dasatinib-treated non-Tg animals. Accordingly, Tg-C73A mice and non-Tg mice treated with dasatinib exhibited improved behavioral outcomes in motor (rotarod) and cognitive (Morris water maze) assays compared to controls. Moreover, the activity of Src kinases, along with oxidative stress, were significantly diminished in Tg-C73A brains. Together, these data demonstrate that oxidation of KCNB1 channels is a contributing mechanism to cellular and behavioral deficits in vertebrates and suggest a new therapeutic approach to TBI.SIGNIFICANCE STATEMENTThis study provides the first experimental evidence that oxidation of a K+channel constitutes a mechanism of neuronal and cognitive impairment in vertebrates. Specifically, the interaction of KCNB1 channels with reactive oxygen species plays a major role in the etiology of mouse model of traumatic brain injury (TBI), a condition associated with extensive oxidative stress. In addition, a Food and Drug Administration–approved drug ameliorates the outcome of TBI in mouse, by directly impinging on the toxic pathway activated in response to oxidation of the KCNB1 channel. These findings elucidate a basic mechanism of neurotoxicity in vertebrates and might lead to a new therapeutic approach to TBI in humans, which, despite significant efforts, is a condition that remains without effective pharmacological treatments.Keywords
This publication has 73 references indexed in Scilit:
- c-Abl Inhibition Delays Motor Neuron Degeneration in the G93A Mouse, an Animal Model of Amyotrophic Lateral SclerosisPLOS ONE, 2012
- Inhibition of Src kinase activity attenuates amyloid associated microgliosis in a murine model of Alzheimer’s diseaseJournal of Neuroinflammation, 2012
- Localization-dependent activity of the Kv2.1 delayed-rectifier K + channelProceedings of the National Academy of Sciences, 2010
- Targeting protein kinases in central nervous system disordersNature Reviews Drug Discovery, 2009
- Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences, 2009
- Oxidation of a potassium channel causes progressive sensory function loss during agingNature Neuroscience, 2009
- Effects of Dasatinib on Src Kinase Activity and Downstream Intracellular Signaling in Primitive Chronic Myelogenous Leukemia Hematopoietic CellsCancer Research, 2008
- The Kv2.1 K+ channel targets to the axon initial segment of hippocampal and cortical neurons in culture and in situBMC Neuroscience, 2008
- Apoptotic surge of potassium currents is mediated by p38 phosphorylation of Kv2.1Proceedings of the National Academy of Sciences, 2007
- Pro-NGF secreted by astrocytes promotes motor neuron cell deathMolecular and Cellular Neuroscience, 2007